[1]
|
Saran, R., Robinson, B., Abbott, K.C., et al. (2019) US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 73, A7-A8.
|
[2]
|
Fioretto, P. and Mauer, M. (2007) Histopathology of Diabetic Nephropathy. Seminars in Nephrology, 27, 195-207.
https://doi.org/10.1016/j.semnephrol.2007.01.012
|
[3]
|
Chronic Kidney Disease Prognosis Consortium, Matsushita, K., van der Velde, M., et al. (2010) Association of Estimated Glomerular Filtration Rate and Albuminuria with All-Cause and Cardiovascular Mortality in General Population Cohorts: A Collaborative Meta-Analysis. The Lancet, 375, 2073-2081.
https://doi.org/10.1016/S0140-6736(10)60674-5
|
[4]
|
Nathan, D.M. and DCCT/EDIC Research Group (2014) The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care, 37, 9-16.
https://doi.org/10.2337/dc13-2112
|
[5]
|
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complica-tions in Patients with Type 2 Diabetes (UKPDS 33). The Lancet, 352, 837-853. https://doi.org/10.1016/S0140-6736(98)07019-6
|
[6]
|
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein, H.C., Miller, M.E., et al. (2008) Effects of Intensive Glucose Lowering in Type 2 Diabetes. The New England Journal of Medicine, 358, 2545-2559.
https://doi.org/10.1056/NEJMoa0802743
|
[7]
|
ADVANCE Collaborative Group, Patel, A., MacMahon, S., et al. (2008) Intensive Blood Glucose Control and Vascular Outcomes Inpatients with Type 2 Diabetes. The New England Journal of Medicine, 358, 2560-2572.
https://doi.org/10.1056/NEJMoa0802987
|
[8]
|
Duckworth, W., Abraira, C., Moritz, T., et al. (2009) Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. The New England Journal of Medicine, 360, 129-139. https://doi.org/10.1056/NEJMoa0808431
|
[9]
|
Chen, S.C. and Tseng, C.H. (2013) Dyslipidemia, Kidney Disease, and Cardiovascular Disease in Diabetic Patients. The Review of Diabetic Studies, 10, 88-100. https://doi.org/10.1900/RDS.2013.10.88
|
[10]
|
Hirano, T. (2014) Abnormal Lipoprotein Metabolism in Diabetic Nephropathy. Clinical and Experimental Nephrology, 18, 206-209. https://doi.org/10.1007/s10157-013-0880-y
|
[11]
|
Hayashi, T., Hirano, T., Taira, T., et al. (2008) Remarkable In-crease of Apolipoprotein B48 Level in Diabetic Patients with End-Stage Renal Disease. Atherosclerosis, 197, 154-158. https://doi.org/10.1016/j.atherosclerosis.2007.03.015
|
[12]
|
Kuwabara, T., Mori, K., Mukoyama, M., et al. (2012) Exacerbation of Diabetic Nephropathy by Hyperlipidaemia Is Mediated by Toll-Like Receptor 4 in Mice. Diabetologia, 55, 2256-2266. https://doi.org/10.1007/s00125-012-2578-1
|
[13]
|
Kuwabara, T., Mori, K., Mukoyama, M., et al. (2014) Macrophage-Mediated Glucolipotoxicity via Myeloid-Related Protein 8/Toll-Like Receptor 4 Signaling in Diabetic Nephropathy. Clinical and Experimental Nephrology, 18, 584-592. https://doi.org/10.1007/s10157-013-0922-5
|
[14]
|
De Cosmo, S., Menzaghi, C., Prudente, S., et al. (2013) Role of Insulin Resistance in Kidney Dysfunction: Insights into the Mechanism and Epidemiological Evidence. Nephrology Dialysis Transplantation, 28, 29-36.
https://doi.org/10.1093/ndt/gfs290
|
[15]
|
Jauregui, A., Mintz, D.H., Mundel, P., et al. (2009) Role of Altered Insulin Signaling Pathways in the Pathogenesis of Podocyte Malfunction and Microalbuminuria. Current Opinion in Nephrology and Hypertension, 18, 539-545.
https://doi.org/10.1097/MNH.0b013e32832f7002
|
[16]
|
徐诣芝, 王乐, 张凤, 等. 非酒精性脂肪性肝病男性患者的冠心病发病风险与血管紧张素II水平的相关性研究[J]. 重庆医科大学学报, 2013, 38(1): 68-72.
|
[17]
|
Matsuzawa, Y., Funahashi, T., Kihara, S., et al. (2004) Adiponectin and Metabolie Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 29-33. https://doi.org/10.1161/01.ATV.0000099786.99623.EF
|
[18]
|
Hamaguchi, M., Kojima, T. and Takeda, N. (2007) Nonalcoholic Fatty Liver Disease Is a Novel Predictor of Cardiovascular Disease. World Journal of Gastroenterology, 13, 1579-1584. https://doi.org/10.3748/wjg.v13.i10.1579
|
[19]
|
Simental-Mendia, L.E., Rodriguez-Moran, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. https://doi.org/10.1089/met.2008.0034
|
[20]
|
Du, T., Yuan, G., Zhang, M., et al. (2014) Clinical Usefulness of Lipid Ratios, Visceral Adiposity Indicators, and the Triglycerides and Glucose Index as Risk Markers of Insulin Resistance. Cardiovascular Diabetology, 13, 146.
https://doi.org/10.1186/s12933-014-0146-3
|
[21]
|
Guerrero-Romero, F., Simental-Mendia, L.E., Gonzalez-Ortiz, M., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology & Metabolism, 95, 3347-3351. https://doi.org/10.1210/jc.2010-0288
|
[22]
|
Lee, E.Y., Yang, H.K., Lee, J., et al. (2016) Triglyceride Glucose Index, a Marker of Insulin Resistance, Is Associated with Coronary Artery Stenosis in Asymptomatic Subjects with Type 2 Diabetes. Lipids in Health and Disease, 15, 155.
https://doi.org/10.1186/s12944-016-0324-2
|
[23]
|
Pham, H., Robinson-Cohen, C., Biggs, M.L., et al. (2012) Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults. Clinical Journal of the American Society of Nephrology, 7, 588-594.
https://doi.org/10.2215/CJN.11861111
|
[24]
|
Cho, Y., Ann, S.H., Won, K., et al. (2019) Association between Insu-lin Resistance, Hyperglycemia, and Coronary Artery Disease According to the Presence of Diabetes. Scientific Reports, 9, Article No. 6129.
https://doi.org/10.1038/s41598-019-42700-1
|
[25]
|
Budoff, M. (2016) Triglycerides and Triglyceride-Rich Lipo-proteins in the Causal Pathway of Cardiovascular Disease. The American Journal of Cardiology, 118, 138-145. https://doi.org/10.1016/j.amjcard.2016.04.004
|
[26]
|
Hansen, T., Ahlstrom, H., Soderberg, S., et al. (2009) Visceral Adipose Tissue, Adiponectin Levels and Insulin Resistance Are Related to Atherosclerosis as Assessed by Whole-Body Magnetic Resonance Angiography in an Elderly Population. Atherosclerosis, 205, 163-167. https://doi.org/10.1016/j.atherosclerosis.2008.11.007
|
[27]
|
孙卫平, 廖利珍. 胰岛素对新诊断2型糖尿病炎症脂肪因子的影响[J]. 中国现代医学杂志, 2015, 25(22): 55-58.
|
[28]
|
谭曦舒, 李立群, 胡玲玲, 等. OSAHS患者HCY、SAA水平与认知功能的关系研究[J]. 中国现代医学杂志, 2017, 27(1): 82-85.
|
[29]
|
穆云. 血清淀粉样蛋白A在类风湿关节炎患者体内的表达及其受体与血管形成关系的研究[D]: [硕士学位论文]. 天津: 天津医科大学, 2012.
|
[30]
|
盛秀芝, 蔡溢, 王涛. 血清淀粉样蛋白A在糖尿病肾病早期诊断中的价值[J]. 中国实验诊断学, 2010, 14(5): 728.
|
[31]
|
白伟, 刘建凤, 王艳霞, 等. 2型糖尿病肾病患者血清淀粉样蛋白A水平[J]. 中国中西医结合肾病杂志, 2011, 12(4): 337-338.
|
[32]
|
吴云, 展秀君, 王艳荣. 血清同型半胱氨酸、胱抑素C及尿微量白蛋白联合检测在糖尿病早期肾病中的意义[J]. 中国现代医生, 2019, 57(32): 119-122.
|
[33]
|
Trakaki, A., Scharnagl, H., Trieb, M., et al. (2020) Prolonged Bed Rest Reduces Plasma High-Density Lipoprotein Levels Linked to Markedly Suppressed Cholesterol Efflux Capacity. Scientific Reports, 10, Article No. 15001.
https://doi.org/10.1038/s41598-020-71921-y
|
[34]
|
Makinen, S., Nguyen, Y.H., Skrobuk, P., et al. (2013) Mecha-nisms of Insulin Resistance. Duodecim, 129, 2115-2122.
|
[35]
|
Xiang, M., Wang, P.X., Wang, A.B., et al. (2016) Tar-geting Hepatic TRAF1-ASK1 Signaling to Improve Inflammation, Insulin Resistance, and Hepatic Steatosis. Journal of Hepatology, 64, 1365-1377.
https://doi.org/10.1016/j.jhep.2016.02.002
|
[36]
|
Son, J.W., Jang, E.H., Kim, M.K., et al. (2011) Diabetic Reti-nopathy Is Associated with Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Re-search and Clinical Practice, 91, 253-259.
https://doi.org/10.1016/j.diabres.2010.11.005
|
[37]
|
Avogaro, A., Giorda, C., Maggini, M., et al. (2007) Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of Microvascular Complications, Treatment, and Geographic Location. Diabetes Care, 30, 1241-1247.
https://doi.org/10.2337/dc06-2558
|
[38]
|
Brownrigg, J.R., Hughes, C.O., Burleigh, D., et al. (2016) Microvascular Disease and Risk of Cardiovascular Events among Individuals with Type 2 Diabetes: A Population-Level Cohort Study. The Lancet Diabetes & Endocrinology, 4, 588-597. https://doi.org/10.1016/S2213-8587(16)30057-2
|